To evaluate the incidence, pattern and clinical importance of endotoxemia in septic shock, frequent, serial endotoxin determinations were made prospectively in patients with shock. Detectable endotoxin occurred in 43 of 100 patients with septic shock, hut in only one often patients with shock due to nonseptic causes. During septic shock, endotoxemia frequently occurred in the absence of Gram-negative bacteremia. Using a logistic regression model, multiple organ failure occurred 10.3 times more frequently and depression of left ventricular ejection fraction (S45 per cent) 4.8 times more frequently in endotoxemic patients. In patients with positive blood cultures, endotoxemia was associated with a high mortality. We conclude that endo toxemia occurs frequently in septic shock and is associated with severe manifestations of this syndrome, including cardiac depression and multiple organ failure. This study suggests that endotoxin is an important mediator of septic shock and supports efforts to develop anti-endotoxin ther apies for treating patients with this disease. (Chest 1991; 99:169-75) 
To evaluate the incidence, pattern and clinical importance of endotoxemia in septic shock, frequent, serial endotoxin determinations were made prospectively in patients with shock. Detectable endotoxin occurred in 43 of 100 patients with septic shock, hut in only one often patients with shock due to nonseptic causes. During septic shock, endotoxemia frequently occurred in the absence of Gram-negative bacteremia. Using a logistic regression model, multiple organ failure occurred 10.3 times more frequently and depression of left ventricular ejection fraction (S45 per cent) 4.8 times more frequently in endotoxemic patients. In patients with positive blood cultures, endotoxemia was associated with a high mortality. We conclude that endo toxemia occurs frequently in septic shock and is associated with severe manifestations of this syndrome, including cardiac depression and multiple organ failure. This study suggests that endotoxin is an important mediator of septic shock and supports efforts to develop anti-endotoxin ther apies for treating patients with this disease. (Chest 1991; 99:169-75) EU = endotoxin units TT'ndotoxin, a lipopolysaccharide found in Gram--*â€"1 negative bacteria, has been considered by many to be the most important toxin involved in the development of septic shock.1'5However, direct meas urement of circulating endotoxin in septic patients has not consistently correlated with important clinical events such as bacteremia, shock and death.** Al though the use of the linuilus amebocyte lysate assay to measure endotoxin has been shown to be sensitive,9 relatively specific" "' and to correlate with in vivo toxicity," a number of problems have been identi fied. s'12-'4 Many clinical studies on endotoxemia relied on a limulus amebocyte lysate assay that used gelation as an endpoint,H but clinically significant endotoxemia may occur below the sensitivity of this test. 17 Further, endotoxin is rapidly cleared from the circulation in the normal animal or human host.'s-IBTransient epi sodes of endotoxemia may go undetected when only single or infrequent endotoxin determinations are performed.
Several recent reports have avoided some of these limitations by using a chromogenic limulus amebocyte lysate assay that is very sensitive and quantifiable and serial sample collection.17-" These investigations re vealed associations between endotoxemia and Gramnegative bacteremia,17 clinically defined septicemia"1 and the development of ARDS1" in various patient populations. Further, a recent report correlated en dotoxemia with several important clinical endpoints (renal failure, ARDS, severe shock and death) but specifically only studied patients with systemic meningococcal disease. 20 In this investigation, we prospectively evaluated the occurrence of"endotoxemia in septic shock. Frequent, serial endotoxin determinations were made using a sensitive chromogenic limulus amebocyte lysate assay in 110 consecutive patients admitted to a medical intensive care unit with shock. One hundred patients were diagnosed as having septic shock, and ten pa tients were found to have nonseptic causes of shock. All patients were hemodynamically monitored and underwent sequential, comprehensive cardiovascular evaluations including radionuclide-determined left ventricular ejection fractions. The role of endotoxin in the laboratory and hemodynamic abnormalities, organ failure, cardiac depression and mortality of septic shock was examined.
METHODS

Piitinitx
All patients admitted to the medical Intensive Care Unit ol the National Institutes ol Health between December 198-4and February 1987 were considered lor this investigation. Prospective criteria for study entry included fever (temperature >38Â°C),hypotension (mean arterial pressure Â£60 mm Hg), a normal or high cardiac output (cardiac index a.1.0 Umin/m2) and no discernible cause for shock other than septicemia. Of the 113 consecutive patients who met this clinicul definition of septic shock, 100 consented to participate in the study. Ten additional patients with an identifiable nonseptic cause of shock (hemorrhage in five patients, adrenal insufficiency in two patients, and myocardial infarction, pulmonary embolus and neurogenic shock in one patient each) and without fever or positive blood cultures also gave informed consent and were evaluated.
Hemodynamic and iMboratory Evaluation
All patients were monitored using systemic and pulmonary artery catheters. Patients were evaluated and treated using a standardized protocol as previously outlined.2122 Briefly, serial hemodynamic profiles were obtained on each patient every 4 hs from the time of admission to the intensive care unit until the shock resolved or the patient died. Hemodynamic profiles included heart rate, mean arterial pressure, central venous pressure, pulmonary capillary wedge pressure and thermodilution cardiac output. Systemic vas cular resistance was calculated by the standard formula.21 In addition, serial left ventricular ejection fractions were determined using gated radionuclide scans.21 Shock (mean arterial pressure s 60 mm Hg) was treated initially by fluid resuscitation to maintain a pulmonary wedge pressure of 12 to 15 mm Hg. If hypotension persisted, dopamine was started and titrated to a dose Â£20 lig/kg/ min as required. If hypotension still persisted, norepinephrine was started and the dopamine was decreased to renal perfusion levels (2 to 4 (ig/kg/min).
Routine laboratory tests were performed at least three times daily and included arterial blood gas determinations, serum elec trolyte values, blixxl urea nitrogen concentration, creatinine level, lactate concentration, complete blixxi cell counts, prothrombin time, partial thromboplastin time and fibrinogen levels. Standard liver function tests were done daily. At study entry, three sets of blood cultures from different sites and a urine culture were obtained from all patients. Subsequent bl(x>d and urine cultures were collected as required for the evaluation of new or persistent fever. Sputum cultures were obtained on all intubated patients and as clinically indicated.
Endotmin Determinations
Serial blood samples were collected in sterile, pyrogen-free glass tubes containing preservative-free heparin (5 USP units/ml of blood) every 4 hs for the initial 24 hs, every 12 hs for the next 24 hs, and then daily for three days. The blood was centrifuged at 2,000 g for 10 min and the plasma stored at â€"¿ 20Â°Cuntil assayed. A chromogenic limulus amebocyte lysate assay (Whittaker M. A. Biopnxlucts, Walkersville, MD) was used to measure endotoxin. In previous investigations, we have not observed a difference between plateletrich and platelet-poor plasma with this assay.23 A total of 1,064 endotoxin determinations were performed on 110 patients by one technologist blinded to the clinical data.
On the day of the assay, specimens were thawed, diluted 1:10 with pyrogen-free distilled water and then heated to 100Â°Cfor 10 min to remove nonspecific activators or inhibitors of limulus amebocyte lysate. The treated sample (50 \i\) and limulus amebocyte lysate (50 u.1) were then incubated together for 10 min at 37Â°Cin pyrogen-free plastic microtiter tissue culture plates (Costar, Cam bridge, MA). Chromogenic substrate (100 fil) was added to the reaction mixture followed by 3 min of continued incubation. Endotoxin in a specimen activates a proenzyme in the lysate that then cleaves p-nitroaniline from the chromogenic substrate. The reaction was stopped by the addition of 50 percent glacial acetic acid (100 u.1) and absorbances were measured spectrophotometrically at 405 nm (Titerteck, Multiscan MC, Flow Laboratories, McLean, VA). The absorbance of an aliquot of each diluted plasma sample, processed without limulus amebocyte lysate or substrate, was subtracted from the absorbance of the measured aliquot to correct for the intrinsic color of individual specimens. The endotoxin concentration in endotoxin units per milliliter of plasma (1 EU = 100 pg of US standard endotoxin) was then read from a standard curve based on known amounts of purified reference endotoxin assayed in H2O. This method is sensitive to 10 pg/ml of US standard endotoxin. All endotoxin-negative samples were retested using pyrogen-free glass tubes and a 30-min incubation, which increases the sensitivity of the assay to 1 pg/ml. Patient samples containing endotoxin concentrations higher than the upper limit of the standard curve were diluted further and retested. All positive patient specimens were confirmed by repeat analysis. A reference sample of pooled plasma spiked with a known quantity of endotoxin was run with each assay to assess the efficiency of endotoxin recovery. The plasma samples from the seven patients found to have Candida septicemia also were assayed using a limulus amebocyte lysate fraction that is nonreactive with yeast cell wall components (Endospecy, Seikagaku Kogyo Co Ltd, Tokyo, Japan).24 Similar results were obtained for the two assays.
Quantitation of Serum C^-like Activity
Serum samples were collected at the time of study entry and then daily for determination of C^-like activity. The C,.-like activity was measured using a semiquantitative bioassay technique based on neutrophil aggregation as previously described. 
Definition of Clinical Endpoints
Clinical endpoints were defined prospectively and each deter mination was made by two clinicians without access to the endotoxin data. The development of renal insufficiency was defined as a serum creatinine of 5:180 u,mol/L (2 mg/dl) with an acute rise of Â£50 percent over baseline, pre-shock creatinine concentrations. The ARDS was diagnosed by four criteria: hypoxemia requiring a fractional inspired oxygen concentration S40 percent to maintain the partial pressure of arterial oxygen >60 mm Hg; roentgenographic findings of bilateral alveolar or interstitial infiltrates or both; normal intravascular volume with a pulmonary wedge pressure s 18 mm Hg; and an appropriate clinical setting (the absence of another specific pulmonary diagnosis). Patients were considered to have survived the episode of shock if they were discharged from the intensive care unit or were still alive without signs of shock two weeks after entering the study.
Statistics
Means are expressed plus or minus the standard error of the mean in the text, tables and figures. In addition to the septic and nonseptic shock groups, septic patients were divided by the presence or absence of either detectable endotoxemia or documented bacteremia. For the purpose of analysis, certain variables that were determined more than once for each patient needed to be repre sented by one number which accurately reflected disease severity. Lactate concentrations, C,.-like activity and bilii iibin levels were summarized by using the single highest (peak) determination ( All reported p values are two-tailed. Ejection fractions were first compared among groups by doing an analysis of variance. Since this result was statistically significant (p = 0.0001), group pairs were compared using ( tests without inflating the experiment-wise error rate.
Multivariate analysis was performed using a logistic regression model.* The clinical outcomes of renal insufficiency, ARDS, or Left Ventricular Ejection Fraction (%) FIGURE 1. Nadir left ventricular ejection fractions in patients with nonseptic shock (n = 10), septic shock without endotoxemia (n = 57) and septic shock with endotoxemia (n = 43).
both, and severe shock requiring vasopressors (dopamine a5 u,g/ kg/min or norepinephrine) were all significantly associated with mortality (p<0.05, chi square test), and each was analyzed sepa rately as a dependent variable. Eight independent variables were used in each logistic regression.
RESULTS
A comparison of the septic and nonseptic patient groups is summarized in Table 1 . Clinical character istics and the severity of shock were similar between the two groups. Lactate levels were higher in the patients with shock due to nonseptic causes (p = 0.023) and ejection fractions were depressed in the septic shock group (p = 0.010). Detectable endotoxemia (lev els >0.1 EU/ml) occurred at one or more time points in 43 of 100 patients with septic shock, but only in one of 10 patients (p = 0.042) with shock due to nonseptic causes. This latter patient, who had hepatic failure (hepatitis B and delta agent) and fatal hemorrhagic shock, had one specimen with detectable endotoxin and the concentration was low (0.18 EU/ ml). The mean peak endotoxin concentration of the septic patients was 4.4 Â±1.2 EU/ml (meanÂ±SEM), equivalent to 440 pg/ml of US Standard Endotoxin.
Twenty patients were endotoxemic at study entry (Fig 2) . Patients who eventually developed endotoxe mia did so by 20 hs, except for one who turned positive at 72 hs. Eleven patients were persistently endotoxe mic on the first day of evaluation. Despite the admin istration of appropriate antibiotics, endotoxin concen trations rose above entry levels in these 11 patients, with the mean endotoxin concentration of this group peaking at 4 hs after the start of sample collection. The majority of patients, however, had intermittent endotoxemia during the study. The average number of specimens positive for endotoxin per patient was 4.4 Â±0.4(meanÂ±SEM). Twenty-three of 43 patients with endotoxemia had four or more samples that tested positive. Only four of 43 patients had only one positive test. All patients who recovered became endotoxin-negative. Ten of the 12 nonsurvivors with endotoxemia had no detectable plasma endotoxin before they died.
Patients with septic shock testing positive for en dotoxin are compared with those testing negative in Table 2 . The groups did not differ significantly in age or underlying disease, though there were more pa tients with AIDS in the endotoxin-negative group (p = 0.08). The presence of endotoxemia was associated with positive blood cultures (p = 0.003), lactic acidemia (p = 0.002), increased serum C5a-like activity (p = 0.013) and a low fibrinogen level (p = 0.018).
Hypotension was immediately treated with fluid resuscitation or vasoactive drugs, or both, as clinically indicated. Cardiovascular measurements sensitive to these manipulations, such as mean arterial pressure and pulmonary wedge pressure, did not differ between patient groups. However, patients with endotoxemia did have low systemic vascular resistances (p = 0.013) and depressed ejection fractions (p = 0.0001) com pared with patients without detectable endotoxemia ( Table 2 ). Figure 1 shows the mean nadir ejection fractions for septic patients with and without endo toxemia and for nonseptic patients. Ejection fractions in the septic patients with endotoxemia also were depressed relative to the nonseptic shock group (p = 0.0003). Clinically septic patients without endo toxemia did not have ejection fractions significantly lower than the nonseptic group (p = 0.094).
Clinical outcomes associated with the presence of circulating endotoxin (Table 2) patients with endotoxemia, but these differences were not significant. Quantitative endotoxin concentrations (data not shown) did not correlate with the laboratory findings, cardiovascular changes or outcomes.
Although positive blood cultures were found twice as frequently in patients with endotoxemia as in those without, only 26 percent of the endotoxemic patients had documented
Gram-negative bacteremia. Con versely, 14 percent of endotoxin-negative patients grew Gram-negative organisms from their blood. Endotoxe mia occurred frequently in patients with negative blood cultures. Further, circulating endotoxin was found in some patients with isolated Gram-positive bacteremia (eight of 14 patients) or Candida septicemia (four of four patients). Endotoxemic patients with Gram-negative bacteremia had higher peak endotoxin concentrations than those with Gram-positive bacte remia; this difference approached but did not achieve statistical significance (5.23 Â±2.18 vs 1.44 Â±0.38 EU/ ml; p = 0.054). Both of these groups, however, had similar laboratory results, cardiovascular abnormali ties and clinical outcomes. Likewise, Candida septi cemia with concomitant Gram-negative bacteremia (three of seven patients) resulted in higher but not significantly different endotoxin concentrations com pared with those for Candida sepsis alone (14.51 Â±5.01 vs 2.42 Â± 2.02 EU/ml; p = 0.162). Other measurements and outcomes also were similar between these sub groups. Separate analysis of the 37 patients with septic shock documented by positive blood culture yielded many of the same associations that had been identified for the entire group (Table 3) . Culture-positive, endo toxemic patients were more likely to develop renal insufficiency (p = 0.021), ARDS (p = 0.003) or both (p = 0.0038) than culture-positive, nonendotoxemic patients. Notably, in these patients with proven bac teremia, the presence of circulating endotoxin was associated with higher mortality (p = 0.034).
We performed multivariate analysis for six outcomes (Table 4) . Male gender was the only independent variable of the eight used in the logistic regression model that had a significant effect on mortality (odds ratio 3.5, p = 0.05). Patients with endotoxemia were 3.6 times more likely to develop renal insufficiency (p = 0.036) and 10.3 times more likely to have renal insufficiency and ARDS (p = 0.006). Endotoxemia also was strongly predictive of sepsis-induced depression of the ejection fraction (odds ratio 4.8, p = 0.006). ARDS was 2.8 times more frequent in patients^50 years old (p = 0.038), and multiorgan failure was asso ciated with a low systemic vascular resistance (odds ratio 5.4, p = 0.022). Severe shock requiring the use of vasopressors to maintain a mean arterial pres sure &60 mm Hg was associated with male gender (odds ratio 3.2, p = 0.026), lactate concentrations >4 mmol/L (odds ratio 3.8, p = 0.030) and a systemic vascular resistance <500 dynes's'cm~5(odds ratio 3.9, p = 0.010).
DISCUSSION
Although endotoxin has generally been presumed to be the major bacterial toxin responsible for the septic shock syndrome, the detection of circulating endotoxin in human sepsis has correlated inconsis tently with both bacteremia and important clinical endpoints.6""-27 Using a prospective design, a sensitive chromogenic limulus amebocyte lysate assay, and serial sampling, the present investigation found that endotoxemia occurred commonly, though intermit tently, in established human septic shock. Further, the presence of endotoxemia was closely associated with important manifestations and outcomes of this syn drome. Circulating endotoxin, however, was not com monly found in patients with nonseptic causes of shock, despite the high mortality (50 percent) that occurred in this group. The concentrations of endo toxin detected in most of our patients (mean peak concentration of 440 pg/ml) were similar to those of other recent studies,17"19 but below the sensitivity of the older gelation limulus amebocyte lysate assay used in the majority of previous studies of endotoxemia in humans.7-" Further, reliance on sample collection only at study entry would have missed over half the cases of endotoxemia in our patient population because endotoxemia was intermittent (Fig 2) .
Seventy-four percent of our clinically diagnosed cases of septic shock with detectable endotoxemia did not have documented Gram-negative septicemia. This suggests that endotoxin can persist or possibly increase28 in the circulation after host defenses or antibiotics, or both, have rendered blood cultures negative. Further, extravascular sources of endotoxin, such as the gastrointestinal tract29 or sequestered foci of infection, may be important in causing detectable endotoxemia in some patients. In contrast, not all patients with Gram-negative bacteremia were found to be endotoxemic.
This well described phenomenon6'7-1"-19-27 probably is attributable to low levels of bacteremia with rapid clearance of any free endotoxin from the circulation. Notably, we found circulating endotoxin in some cases of Gram-positive or Candida septicemia, a finding that has been reported previously.6J-ls-24 We do not believe that these are falsepositives due to assay nonspecificity. Gram-positive products react with limulus amebocyte lysate only at very high concentrations,30 and in a previous canine investigation23 our limulus amebocyte lysate assay detected no endotoxemia despite very high levels of Gram-positive bacteremia. Several other clinical in vestigations did not find endotoxemia in cases of Grampositive bacteremia, but they did not specifically examine patients with septic shock.9 I7-272IS Since cell wall components of Candida species have been re ported to produce false-positive limiilns tests,24-31 we retested the samples from patients with candidemia using a non-cross-reacting assay fraction-1 and found endotoxin still present in these samples. We suspect that endotoxemia does occur in some cases of septicshock caused by Gram-positive bacteria and Candida species. The source of this endotoxemia may be undetected Gram-negative bacteremia or alternatively release of endotoxin from extravascular sites. A substantial number of our patients with septicshock (53 of 1(K))were found to have no detectable endotoxemia despite frequent, serial testing. The absence of endotoxemia in these cases may be due to its rapid clearance from the circulation. 15-mA small bolus of endotoxin given to normal volunteers5 will produce cardiovascular changes that persist for hours, yet endotoxin is undetectable in the blood (unpub lished observation), presumably due to rapid clear ance. Conversely, endotoxin may be sequestered at local sites of infection but still result in the systemicrelease of endogenous mediators. Further, toxins other than endotoxin may be wholly or partially responsible for producing the septic shock syndrome in some patients. Studies using our canine model of septicshock, which closely simulates many features of the human syndrome, suggest that endotoxin is sufficient but not necessary to induce the pathophysiologic changes typical of septic shock. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] In contrast to endotoxemia, positive blood cultures or the presence of Gram-negative bacteremia were not associated with any measures of disease severity or predictive of outcome. Patients with bacteremia had similar clinical courses as those without bactere mia. Patients with Gram-negative sepsis did not have significantly worse clinical outcomes than patients with Gram-positive sepsis. Despite the association of endotoxemia with the severe manifestations of septicshock, the routine performance of the limulus amebocyte lysate assay probably would not have changed patient management. A positive limulus test would not have been useful in guiding the selection of antibiotic therapy since it did not predict the presence of Gram-negative sepsis or the absence of Grampositive or fungal sepsis. Since all of our patients were already critically ill by definition, the presence of endotoxemia alone did not portend the need for intensive care.
Although qualitatively the presence of endotoxemia was associated with severe septic shock and organ injury in this study, quantitative levels did not correlate with cardiovascular changes, laboratory abnormalities or outcome. This is in contrast to a recent study of endotoxemia in patients with systemic meningococcal disease where endotoxin concentrations quantitatively correlated with severe shock, organ failure and mor tality.22This study differed from ours, however, in that all the patients were infected with the same species of Gram-negative organism. In our canine model of septicshock, we have found that different Gram-negative bacteria vary profoundly in the amount of in vivo endotoxemia they produce/" In this study, the Gramnegative organism that produced the least amount of endotoxemia caused more severe hypotension, greater myocardial depression and a higher mortality. Further, animals with leukopenia (following a nonlethal dose of radiation) challenged with a nonlethal dose of Enchericliia coli had a high mortality without greater car diovascular dysfunction or higher endotoxin concen trations. We postulated that bacterial products other than endotoxin and host-related factors may be im portant contributors to toxicity and mortality in some cases of Gram-negative septic shock. Extrapolating these findings to the current study suggests that quantitative endotoxin concentrations may correlate poorly with the severity of septic shock when compar ing patients differing in their ability to compensate for a given insult and infected with a variety of microor ganisms, some of which may produce non-eudotoxin substances that add to toxicity.
Septic shock in humans produces characteristic Cardiovascularchanges including a low systemic vas cular resistance, high cardiac output, a dilated ventri cle and a depressed left ventricular ejection fraction. The fall in ejection fraction typically occurs in the first two days after the onset of septicemia and is reversible in those who survive more than seven to ten days.2' This same pattern of cardiovascular injuryhas been observed in an experimental canine model in response to Gram-negative bacteria,:M Gram-posi tive bacteria,2^tumor necrosis factor52and endotoxin. 32 In the current study, nadir left ventricular ejection fractions were significantly lower in patients with septic shock compared to nonseptic patients with shock. Further, within the septic group, the occur rence of endotoxemia was associated with markedly depressed ejection fractions. These findings are con sistent with the previously described animal studies showing that eudotoxin alone (possibly through the induction of endogenous mediators such as tumor necrosis factor) can produce this type of myocardial depression. 32 In the present study of patients with septic shock, endotoxemia was associated with important laboratory, cardiovascular and clinical consequences of sepsis including lactic acidemia, myocardial dysfunction, organ failure in the subset of patients with documented bacteremia, death. Previous studies have shown that persistent hypotension (due to a low systemic vascular resistance or severe myocardial depression, or both) or multiple organ system failure are the most frequent causes of death in septic shock. 15 The associations documented in the present study provide strong evidence that endotoxin is an important mediator of the high morbidity and mortality of septic shock.
